The frequency of co-occurrence of Hashimoto disease in granulomatous mastitis patients and its relation to hematological parameters


Özdemir B. A., Kocaöz S., Yazicioğlu Ö., Çomçali B., Savaş F., Karaca O., ...Daha Fazla

Medicine (United States), cilt.105, sa.20, ss.1-5, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 105 Sayı: 20
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1097/md.0000000000048758
  • Dergi Adı: Medicine (United States)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.1-5
  • Anahtar Kelimeler: C-reactive protein, Hashimoto thyroiditis, Idiopathic granulomatous mastitis, lymphocyte-to-monocyte ratio, neutrophil-to-lymphocyte ratio
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background: – Idiopathic granulomatous mastitis (IGM) is a benign, chronic inflammatory breast disease frequently associated with autoimmune disorders. This prospective cohort study explored the prevalence of Hashimoto thyroiditis (HT) in patients with IGM and the relationship between this co-occurrence and systemic inflammatory markers. Methods: – Between March 2019 and September 2022, 179 women were enrolled: IGM without HT (n = 52), IGM + HT (n = 19), and age-matched healthy controls (n = 89). Hematological indices, including white blood cell count, C-reactive protein, neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to-monocyte ratio (LMR), were measured at diagnosis before any treatment. Results: – The prevalence of HT among patients with IGM was 26.8 %. Compared with isolated IGM, the IGM + HT group had a lower smoking rate (16.3% vs 40.4%, P = .028) and displayed a significantly lower median NLR (1.91 vs 2.76, P < .001) but higher median LMR (6.47 vs 4.75, P = .001). Conclusion: – Approximately 1 in 4 women with IGM also had HT. A low NLR-high LMR pattern may reflect a distinct inflammatory milieu in this overlap cohort and could help tailor follow-up strategies for these patients. Routine thyroid screening should be considered in patients with IGM.